Difficulties in demonstrating long term immunity in FeLV vaccinated cats due to increasing age-related resistance to infection
<p>Abstract</p> <p>Background</p> <p>Feline leukaemia virus (FeLV) is a pathogen causing fatal illness in cats worldwide, and as such there is a high demand for products to protect against disease. The duration of immunity provided by an inactivated FeLV vaccine, Versif...
Main Authors: | Wilson Stephen, Greenslade Juliet, Saunders Gillian, Holcroft Catherine, Bruce Lynn, Scobey Andy, Childers Tedd, Sture Gordon, Thompson James |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1746-6148/8/125 |
Similar Items
-
The Diagnosis of Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats in Australia
by: Mark Westman, et al.
Published: (2019-05-01) -
Comparative measurement of FeLV load in hemolymphatic tissues of cats with hematologic cytopenias
by: Mehdi Abdollahi-Pirbazari, et al.
Published: (2019-12-01) -
Feline immunodeficiency virus (FIV), feline leukaemia virus (FeLV) and Leishmania sp. in domestic cats in the Midwest of Brazil
by: Daniella Poffo, et al. -
Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha
by: Esperanza Gomez-Lucia, et al.
Published: (2019-09-01) -
FeLV-infection: problems and prospects of vaccine prevention and interferon-therapy of feline leukemia
by: T. V. Moskvina, et al.
Published: (2021-09-01)